Mari Terada

InstitutionDisease Control and Prevention Center
AddressTokyo
Japan
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 13 Covid-19 publications, with a maximum of 2 publications in June 2020 and January 2021 and April 2021 and June 2021
    All Publications
    Bar chart showing 14 publications over 3 distinct years, with a maximum of 9 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Matsunaga N, Hayakawa K, Terada M, Ohtsu H, Asai Y, Tsuzuki S, Suzuki S, Toyoda A, Suzuki K, Endo M, Fujii N, Suzuki M, Saito S, Uemura Y, Shibata T, Kondo M, Izumi K, Terada-Hirashima J, Mikami A, Sugiura W, Ohmagari N. Clinical Epidemiology of Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan: Report of the COVID-19 Registry Japan. Clin Infect Dis. 2021 12 06; 73(11):e3677-e3689. PMID: 32986793.
      Citations: 27     Fields:    Translation:Humans
    2. Togano T, Uemura Y, Asai Y, Hayakawa K, Matsunaga N, Terada M, Ohtsu H, Suzuki S, Toyoda A, Hara H, Sato R, Ishikane M, Kinoshita-Iwamoto N, Hangaishi A, Ohmagari N. The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan. J Infect Chemother. 2021 Oct; 27(10):1498-1503. PMID: 34340930.
      Citations: 1     Fields:    Translation:Humans
    3. Terada M, Ohtsu H, Saito S, Hayakawa K, Tsuzuki S, Asai Y, Matsunaga N, Kutsuna S, Sugiura W, Ohmagari N. Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan. BMJ Open. 2021 06 15; 11(6):e047007. PMID: 34130961.
      Citations: 3     Fields:    Translation:Humans
    4. Citations: 1     Fields:    Translation:HumansPHPublic Health
    5. Ide S, Hayama H, Asai Y, Terada M, Nomoto H, Kutsuna S, Ohmagari N, Hiroi Y. Evaluation of High-Sensitivity Cardiac Troponin T Levels in Japanese Patients Recently Recovered From Coronavirus Disease 2019. Circ J. 2021 05 25; 85(6):944-947. PMID: 33994409.
      Citations:    Fields:    Translation:HumansCells
    6. Inada M, Ishikane M, Terada M, Matsunaga A, Maeda K, Tsuchiya K, Miura K, Sairenji Y, Kinoshita N, Ujiie M, Kutsuna S, Ishizaka Y, Mitsuya H, Ohmagari N. Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies. J Infect Chemother. 2021 Jul; 27(7):1063-1067. PMID: 33962861.
      Citations: 1     Fields:    Translation:Humans
    7. Yamada G, Hayakawa K, Asai Y, Matsunaga N, Ohtsu H, Hojo M, Hashimoto M, Kobayashi K, Sasaki R, Okamoto T, Yanagawa Y, Katagiri D, Terada M, Suzuki M, Sato L, Miyazato Y, Ishikane M, Morioka S, Saito S, Ohmagari N. External validation and update of prediction models for unfavorable outcomes in hospitalized patients with COVID-19 in Japan. J Infect Chemother. 2021 Jul; 27(7):1043-1050. PMID: 33865699.
      Citations:    Fields:    Translation:Humans
    8. Kutsuna S, Asai Y, Matsunaga A, Kinoshita N, Terada M, Miyazato Y, Nakamoto T, Suzuki T, Saito S, Endo M, Kanda K, Kenji M, Takasaki J, Hojo M, Ishizaka Y, Ohmagari N. Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19. J Infect Chemother. 2021 Jun; 27(6):808-813. PMID: 33531292.
      Citations: 3     Fields:    Translation:Humans
    9. Nomoto H, Kutsuna S, Okuma K, Kuramitsu M, Tezuka K, Ikebe E, Saito S, Kinoshita N, Terada M, Endo M, Suzuki T, Miyazato Y, Nakamoto T, Inada M, Hamaguchi I, Ohmagari N. No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity. J Infect Chemother. 2021 Apr; 27(4):653-655. PMID: 33487533.
      Citations: 1     Fields:    Translation:Humans
    10. Saito S, Asai Y, Matsunaga N, Hayakawa K, Terada M, Ohtsu H, Tsuzuki S, Ohmagari N. First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics. J Infect. 2021 04; 82(4):84-123. PMID: 33152376.
      Citations: 41     Fields:    Translation:Humans
    11. Miyazato Y, Morioka S, Tsuzuki S, Akashi M, Osanai Y, Tanaka K, Terada M, Suzuki M, Kutsuna S, Saito S, Hayakawa K, Ohmagari N. Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019. Open Forum Infect Dis. 2020 Nov; 7(11):ofaa507. PMID: 33230486.
      Citations: 15     
    12. Nakamura K, Ide S, Saito S, Kinoshita N, Kutsuna S, Moriyama Y, Suzuki T, Ota M, Nomoto H, Mizoue T, Hojo M, Takasaki J, Asai Y, Terada M, Akiyama Y, Miyazato Y, Nakamoto T, Wakimoto Y, Ujiie M, Yamamoto K, Ishikane M, Morioka S, Hayakawa K, Sugiyama H, Ohmagari N. COVID-19 can suddenly become severe: a case series from Tokyo, Japan. Glob Health Med. 2020 Jun 30; 2(3):174-177. PMID: 33330803.
      Citations: 1     
    13. Citations: 4     
    Terada's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (45)
    Explore
    _
    Co-Authors (120)
    Explore
    _
    Similar People (60)
    Explore
    _